Search Results - "Solovieva, E. Yu"

Influence of chronic pain in osteoarthritis on the risk of cardiovascular diseases and modern methods of drug prevention by Sarvilina, I V, Danilov, Al B, Tkacheva, O N, Gromova, O A, Solovieva, E Yu, Dudinskaya, E N, Rozanov, A V, Kartashova, E A

“…The purpose of the review of scientific medical literature was to evaluate the data of the epidemiology of osteoarthritis (OA) and cardiovascular diseases…”
Get more information

New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council by Danilov, Al. B., Lila, A. M., Majidova, Yo. N., Gromova, O. A., Tkacheva, O. N., Sarvilina, I. V., Kochish, A. Yu, Nazarenko, A. G., Zagorodniy, N. V., Minasov, T. B., Alekseeva, L. I., Taskina, E. A., Kotovskaya, Yu. V., Dudinskaya, E. N., Rozanov, A. V., Solovieva, E. Yu, Shavlovskaya, O. A., Sharov, M. N., Kamchatnov, P. R., Rachin, A. P., Barantsevich, E. R., Iskra, D. A., Yakupov, E. Z., Devlikamova, F. I., Barulin, A. E., Nesterova, M. V., Sakovets, T. G., Barinov, A. N., Dolgova, I. N., Zabolotskikh, N. V., Zonova, E. V., Shchepankevich, L. A., Parfenov, V. A., Dzhurabekova, A. T., Khakimova, S. Z.

“…In recent decades, there has been an increase in the prevalence and medical and social burden of osteoarthritis (OA) and nonspecific back pain in all countries…”
Get full text

From the conception of «oxidizing stress» to the conception of «cell signaling modulation by Solovieva, E Yu, Chipova, D T

“…We discuss the current conception of "oxidizing stress" which covers a wide group of various interrelated phenomena including higher production of reactive…”
Get more information

Phospholipids metabolism disorders in acute stroke by Solovieva, E Yu, Farrahova, K I, Karneev, A N, Chipova, D T

“…The disturbances of cerebral circulation results in the violation of phospholipid metabolism. Activation of lipid peroxidation and protein kinase C and release…”
Get more information

Statin therapy and atherosclerosis stabilization in carotid arteries by Luginova, Z. G, Koshurnikova, M. V, Solovieva, E. Yu, Balakhonova, T. V, Susekov, A. V

“…Atherosclerosis and it’s clinical implications (myocardial infarction, stroke, intermittent lameness) is a serious medico-social problem in Russia. Statins (or…”
Get full text

Treatment of diseases with consequences of traumatic brain injury by Solovieva, E Yu, Karneev, A N, Amelina, I P

“…Traumatic brain injury (TBI) is one of the leading causes of neurological morbidity, disability and mortality in all age groups of the population. As a result…”
Get more information

Imaging of brain activity using fMRI in a patient with subjective cognitive decline by Solovieva, E Yu, Vorob'eva, O V, Fateeva, V V, Skipetrova, L A

“…In clinical practice, subjective cognitive decline (SCD) is often difficult to diagnose because it is not detected by standard neuropsychological and cognitive…”
Get more information

Inhibitors of HMG-Co-A reductase (statins) in the treatment of dyslipidemia and atherosclerosis at the turn of decades by Susekov, A V, Basyrova, E R, Gorniakova, N B, Khokhlova, N V, Rozhkova, T A, Solov'eva, E Iu

Get more information

Simvastatin (40 mg/day) in patients with hereditary hypercholesterolemia: effect on high density lipoprotein cholesterol by Susekov, A V, Solov'eva, E Iu, Zubareva, M Iu, Kukharchuk, V V

“…To study effect of simvastatin of the level of high density lipoprotein (HDL) cholesterol (CH). Simvastatin (40 mg/day) was given for 3 months to 15 patients…”
Get more information